HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miyatake, T. Articles by Soares, M. P. Search for Related Content PubMed PubMed Citation Articles by Miyatake, T. Articles by Soares, M. P.

Complement-Fixing Elicited Antibodies Are a Major Component in the Pathogenesis of Xenograft Rejection¹

Tsukasa Miyatake^*, Koichiro Sato^*, Ko Takigami^*, Nozomi Koyamada^*, Wayne W. Hancock^*, Herve Bazin, Dominique Latinne, Fritz H. Bach^* and Miguel P. Soares^2,*

^* Center for Immunobiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115; and Laboratoire d’Immunologie Experimentale (IMEX), Universite de Louvain, Brussels, Belgium

Hamster to rat cardiac xenografts undergo delayed rejection as compared with the hyperacute rejection of discordant xenografts. Elicited xenoreactive Abs (EXA) are thought to initiate hamster to rat cardiac xenograft rejection. In this study, we demonstrate that following transplantation of a hamster heart, rats generated high levels of EXA. Adoptive transfer into naive recipients of purified IgM, IgG2b, or IgG2c, but not IgG1 or IgG2a EXA, induced xenograft rejection in a complement-dependent manner. Ability of EXA to cause rejection correlated with complement activation, platelet aggregation, and P-selectin expression in the xenograft endothelium. Cyclosporin A (CyA) administration, after transplantation, totally suppressed IgG1, IgG2a, IgG2b, and IgG2c EXA, and inhibited IgM EXA production, but failed to overcome rejection. Administration of cobra venom factor (CVF), 1 day before and at the time of transplantation, resulted in complement inhibition during 3 days after transplantation, which failed to overcome rejection. Combination of CyA and CVF, which we have previously shown to overcome rejection, resulted in suppression of IgG EXA production and in the return of IgM XNA to preimmunization serum levels, 3 to 7 days after xenotransplantation, while complement remained inhibited. Thus, under CyA/CVF treatment, complement activation by hamster cells was suppressed following xenotransplantation, and presumably for this reason xenograft rejection did not occur. In conclusion, our data demonstrate that EXA play a pivotal role in the pathogenesis of xenograft rejection and that CyA and CVF suppress xenograft rejection by preventing exposure of xenograft endothelial cells to complement activation by EXA.

This article has been cited by other articles:

				H. Wang, J. Arp, W. Liu, S. J. Faas, J. Jiang, D. R. Gies, S. Ramcharran, B. Garcia, R. Zhong, and R. P. Rother Inhibition of Terminal Complement Components in Presensitized Transplant Recipients Prevents Antibody-Mediated Rejection Leading to Long-Term Graft Survival and Accommodation J. Immunol., October 1, 2007; 179(7): 4451 - 4463. [Abstract] [Full Text] [PDF]

				T. Hasegawa, K. Okada, Y. Takano, Y. Hiraishi, and Y. Okita Autologous fibrin-coated small-caliber vascular prostheses improve antithrombogenicity by reducing immunologic response J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1268 - 1276. [Abstract] [Full Text] [PDF]

				B. Y. Ma, N. Nakamura, V. Dlabac, H. Naito, S. Yamaguchi, M. Ishikawa, M. Nonaka, M. Ishiguro, N. Kawasaki, S. Oka, et al. Isolation, Cloning, and Characterization of a Novel Phosphomannan-binding Lectin from Porcine Serum J. Biol. Chem., April 27, 2007; 282(17): 12963 - 12975. [Abstract] [Full Text] [PDF]

				S. Saadi, T. Takahashi, R. A. Holzknecht, and J. L. Platt Pathways to Acute Humoral Rejection Am. J. Pathol., March 1, 2004; 164(3): 1073 - 1080. [Abstract] [Full Text] [PDF]

				K. Sato, J. Balla, L. Otterbein, R. N. Smith, S. Brouard, Y. Lin, E. Csizmadia, J. Sevigny, S. C. Robson, G. Vercellotti, et al. Carbon Monoxide Generated by Heme Oxygenase-1 Suppresses the Rejection of Mouse-to-Rat Cardiac Transplants J. Immunol., March 15, 2001; 166(6): 4185 - 4194. [Abstract] [Full Text] [PDF]

				Y. Lin, M. P. Soares, K. Sato, E. Csizmadia, S. C. Robson, N. Smith, and F. H. Bach Long-Term Survival of Hamster Hearts in Presensitized Rats J. Immunol., May 1, 2000; 164(9): 4883 - 4892. [Abstract] [Full Text] [PDF]

				K. Mahboubi, B. C. Biedermann, J. M. Carroll, and J. S. Pober IL-11 Activates Human Endothelial Cells to Resist Immune-Mediated Injury J. Immunol., April 1, 2000; 164(7): 3837 - 3846. [Abstract] [Full Text] [PDF]

				Y. Lin, M. P. Soares, K. Sato, K. Takigami, E. Csizmadia, N. Smith, and F. H. Bach Accommodated Xenografts Survive in the Presence of Anti-Donor Antibodies and Complement That Precipitate Rejection of Naive Xenografts J. Immunol., September 1, 1999; 163(5): 2850 - 2857. [Abstract] [Full Text] [PDF]

				S. Brouard, B. Vanhove, K. Gagne, A. Neumann, P. Douillard, A. Moreau, C. Cuturi, and J. P. Soulillou T Cell Repertoire Alterations of Vascularized Xenografts J. Immunol., March 15, 1999; 162(6): 3367 - 3377. [Abstract] [Full Text] [PDF]

				Y. Lin, M. P. Soares, K. Sato, K. Takigami, E. Csizmadia, J. Anrather, and F. H. Bach Rejection of Cardiac Xenografts by CD4+ or CD8+ T Cells J. Immunol., January 15, 1999; 162(2): 1206 - 1214. [Abstract] [Full Text] [PDF]